Light Mode
$42.30 ↓ -0.84 (-1.95%) Trading Down from the previous close of $43.14, $1.84 below the day’s high of $44.14
+23.90 (+126.66%) / 6M
Momentum, market sentiment, and recent alerts
TRAX reads very good: the 12-month move is +129.9%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.